How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A

Niteesh K Choudhry1, Jeffrey M Singh, Alan Barolet

  • 1Harvard Medical School and Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA. choudhry@fas.harvard.edu

Insights

An invasive strategy for unstable angina/non-ST-segment elevation myocardial infarction reduces re-infarction and hospital readmissions. This approach should be considered for all patients, especially those with ST-segment depression.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Interventional Cardiology

Background:

  • Unstable angina and non-ST-segment elevation myocardial infarction (MI) management involves invasive or conservative strategies.
  • The superiority of these management strategies remains unclear.

Purpose of the Study:

  • To compare the efficacy of invasive versus conservative management strategies for patients with unstable angina or non-ST-segment elevation MI.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) identified through MEDLINE and EMBASE searches.
  • Included seven RCTs with a total of 9212 patients, focusing on follow-up data of at least 3 months.

Main Results:

  • An invasive strategy significantly reduced fatal or nonfatal re-infarction (OR 0.73; 95% CI: 0.61 to 0.88) and hospital readmissions (OR 0.67; 95% CI: 0.48 to 0.94).
  • All-cause mortality was not significantly reduced (OR 0.96; 95% CI: 0.72 to 1.27).
  • Greater benefits from invasive strategies were observed in patients with ST-segment depression and those undergoing revascularization.

Conclusions:

  • An invasive strategy is effective in reducing re-infarction and readmission rates for unstable angina/non-ST-segment elevation MI patients.
  • All-cause mortality was not significantly impacted.
  • An invasive approach is recommended for all patients with unstable angina/non-ST-segment elevation MI, particularly those with ST-segment depression.
Abstract

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...